KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Accumulated Expenses (2016 - 2025)

Evolent Health has reported Accumulated Expenses over the past 11 years, most recently at $65.8 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $65.8 million for Q4 2025, up 95.01% from a year ago — trailing twelve months through Dec 2025 was $65.8 million (up 95.01% YoY), and the annual figure for FY2025 was $65.8 million, up 95.01%.
  • Accumulated Expenses for Q4 2025 was $65.8 million at Evolent Health, up from $60.9 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for EVH hit a ceiling of $194.0 million in Q3 2023 and a floor of $19.4 million in Q1 2021.
  • Median Accumulated Expenses over the past 5 years was $45.1 million (2021), compared with a mean of $65.6 million.
  • Biggest five-year swings in Accumulated Expenses: soared 494.36% in 2022 and later tumbled 83.7% in 2024.
  • Evolent Health's Accumulated Expenses stood at $51.9 million in 2021, then surged by 114.42% to $111.2 million in 2022, then tumbled by 49.29% to $56.4 million in 2023, then tumbled by 40.2% to $33.7 million in 2024, then soared by 95.01% to $65.8 million in 2025.
  • The last three reported values for Accumulated Expenses were $65.8 million (Q4 2025), $60.9 million (Q3 2025), and $38.3 million (Q2 2025) per Business Quant data.